Aerie Pharmaceuticals Net Profit Margin 2012-2019 | AERI

Aerie Pharmaceuticals net profit margin from 2012 to 2019. Net profit margin can be defined as net Income as a portion of total sales revenue.
Aerie Pharmaceuticals Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2019-03-31 $0.03B $-0.24B -702.94%
2018-12-31 $0.02B $-0.23B -1008.70%
2018-09-30 $0.01B $-0.24B -2666.67%
2018-06-30 $0.00B $-0.19B -9350.00%
2018-03-31 $0.00B $-0.16B inf%
2017-12-31 $0.00B $-0.15B inf%
2017-09-30 $0.00B $-0.12B inf%
2017-06-30 $0.00B $-0.11B inf%
2017-03-31 $0.00B $-0.10B inf%
2016-12-31 $0.00B $-0.10B inf%
2016-09-30 $0.00B $-0.09B inf%
2016-06-30 $0.00B $-0.08B inf%
2016-03-31 $0.00B $-0.08B inf%
2015-12-31 $0.00B $-0.07B inf%
2015-09-30 $0.00B $-0.07B inf%
2015-06-30 $0.00B $-0.07B inf%
2015-03-31 $0.00B $-0.06B inf%
2014-12-31 $0.00B $-0.05B inf%
2014-09-30 $0.00B $-0.04B inf%
2014-06-30 $0.00B $-0.04B inf%
2014-03-31 $0.00B $-0.04B inf%
2013-12-31 $0.00B $-0.03B inf%
2013-09-30 $0.00B $-0.02B inf%
2013-06-30 $0.00B $-0.01B inf%
2013-03-31 $0.00B $-0.01B inf%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.876B $0.024B
Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are under developmental stages. Aerie Pharmaceuticals, Inc. is headquartered in Bedminster, New Jersey.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $49.005B 31.31
Takeda Pharmaceutical (TAK) Japan $27.997B 10.36
Grifols (GRFS) Spain $12.562B 15.89
Ionis Pharmaceuticals (IONS) United States $9.716B 21.24
Sage Therapeutics (SAGE) United States $8.748B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.927B 10.86
Neurocrine Biosciences (NBIX) United States $7.168B 0.00
Catalent (CTLT) United States $6.704B 26.91
Nektar Therapeutics (NKTR) United States $5.825B 9.49
Tilray (TLRY) Canada $4.315B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.935B 12.67
United Therapeutics (UTHR) United States $3.888B 0.00
FibroGen (FGEN) United States $3.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.727B 9.82
PTC Therapeutics (PTCT) United States $2.341B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.024B 305.00
Portola Pharmaceuticals (PTLA) United States $1.981B 0.00
Xencor (XNCR) United States $1.931B 52.72
Tricida (TCDA) United States $1.831B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.812B 87.76
Enanta Pharmaceuticals (ENTA) United States $1.789B 24.45
Ironwood Pharmaceuticals (IRWD) United States $1.780B 0.00
USANA Health Sciences (USNA) United States $1.769B 15.37
Zogenix (ZGNX) United States $1.604B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.572B 0.00
Endo (ENDP) Ireland $1.454B 2.34
Heron Therapeutics (HRTX) United States $1.451B 0.00
Esperion Therapeutics (ESPR) United States $1.388B 0.00
Corcept Therapeutics (CORT) United States $1.218B 17.38
TURNING PT THER (TPTX) United States $1.118B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.103B 0.00
Radius Health (RDUS) United States $0.959B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.914B 0.00
TherapeuticsMD (TXMD) United States $0.786B 0.00
ArQule (ARQL) United States $0.784B 0.00
Aptorum Group (APM) China $0.695B 0.00
ChemoCentryx (CCXI) United States $0.688B 0.00
Akebia Therapeutics (AKBA) United States $0.660B 0.00
ORGANOGENESIS (ORGO) United States $0.651B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.635B 0.00
CannTrust Holdings (CTST) Canada $0.621B 0.00
Odonate Therapeutics (ODT) United States $0.613B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.591B 0.00
Dermira (DERM) United States $0.550B 0.00
GlycoMimetics (GLYC) United States $0.522B 0.00
Flexion Therapeutics (FLXN) United States $0.499B 0.00
Translate Bio (TBIO) United States $0.478B 0.00
Siga Technologies (SIGA) United States $0.478B 1.13
Corbus Pharmaceuticals Holdings (CRBP) United States $0.477B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.467B 23.59
KalVista Pharmaceuticals (KALV) United States $0.404B 0.00
Mast Therapeutics (SVRA) United States $0.401B 0.00
Collegium Pharmaceutical (COLL) United States $0.397B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.395B 0.00
Forty Seven (FTSV) United States $0.393B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.384B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.361B 0.00
OptiNose (OPTN) United States $0.359B 0.00
TCR2 Therapeutics (TCRR) United States $0.341B 0.00
Xeris Pharmaceuticals (XERS) United States $0.335B 0.00
Karyopharm Therapeutics (KPTI) United States $0.318B 0.00
CASI Pharmaceuticals (CASI) United States $0.314B 0.00
Dova Pharmaceuticals (DOVA) United States $0.294B 0.00
ImmunoGen (IMGN) United States $0.292B 0.00
Harpoon Therapeutics (HARP) United States $0.278B 0.00
Molecular Templates (MTEM) United States $0.275B 0.00
Concert Pharmaceuticals (CNCE) United States $0.271B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.259B 0.00
Lannett Co Inc (LCI) United States $0.241B 2.34
Aratana Therapeutics (PETX) United States $0.238B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.234B 0.00
Calithera Biosciences (CALA) United States $0.233B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.229B 0.00
MEI Pharma (MEIP) United States $0.228B 0.00
Minerva Neurosciences (NERV) United States $0.227B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.224B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.220B 0.00
Aclaris Therapeutics (ACRS) United States $0.220B 0.00
Rafael Holdings (RFL) United States $0.219B 0.00
Galectin Therapeutics (GALT) United States $0.206B 0.00
Recro Pharma (REPH) United States $0.203B 0.00
Aldeyra Therapeutics (ALDX) United States $0.201B 0.00
Opexa Therapeutics (ACER) United States $0.199B 0.00
IMV INC (IMV) Canada $0.197B 0.00
Nature's Sunshine Products (NATR) United States $0.192B 62.19
Ardelyx (ARDX) United States $0.183B 0.00
Majesco Entertainment (PTE) United States $0.175B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.174B 0.00
Jounce Therapeutics (JNCE) United States $0.167B 0.00
Redhill Biopharma (RDHL) Israel $0.166B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.158B 0.00
Tyme Technologies (TYME) United States $0.151B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.145B 0.00
Neon Therapeutics (NTGN) United States $0.144B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.143B 0.00
Bio Blast Pharma (ENLV) Israel $0.129B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.126B 0.00
Aquestive Therapeutics (AQST) United States $0.122B 0.00
DURECT (DRRX) United States $0.116B 0.00
AgeX Therapeutics (AGE) United States $0.115B 0.00
MediWound (MDWD) Israel $0.113B 0.00
Ocular Therapeutix (OCUL) United States $0.112B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Nivalis Therapeutics (ALPN) United States $0.105B 0.00
Cardiome Pharma (CORV) Canada $0.100B 0.00
Champions Oncology (CSBR) United States $0.099B 0.00
Iterum Therapeutics (ITRM) Ireland $0.098B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.098B 70.00
Natural Alternatives (NAII) United States $0.098B 9.77
Zafgen (ZFGN) United States $0.097B 0.00
ElectroCore (ECOR) United States $0.093B 0.00
China SXT Pharmaceuticals (SXTC) China $0.093B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.083B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Adherex Technologies (FENC) United States $0.081B 0.00
Avenue Therapeutics (ATXI) United States $0.080B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.076B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.074B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Genocea Biosciences (GNCA) United States $0.067B 0.00
Capnia (SLNO) United States $0.062B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.061B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.054B 0.00
CTI BioPharma (CTIC) United States $0.051B 0.00
Novan (NOVN) United States $0.048B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.048B 0.00
AIT Therapeutics (AITB) Israel $0.046B 0.00
KemPharm (KMPH) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.046B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.043B 0.00
Bio-Path Holdings (BPTH) United States $0.043B 0.00
India Globalization Capital (IGC) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.041B 0.00
BioLineRx (BLRX) Israel $0.040B 0.00
Lipocine (LPCN) United States $0.039B 0.00
Melinta Therapeutics (MLNT) United States $0.037B 0.00
ContraFect (CFRX) United States $0.035B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.033B 0.00
IsoRay (ISR) United States $0.030B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
Citius Pharmaceuticals (CTXR) United States $0.028B 0.00
HANCOCK JAFFE (HJLI) United States $0.028B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.024B 3.09
PharmAthene (ALT) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Pain Therapeutics (SAVA) United States $0.018B 0.00
Shineco (TYHT) China $0.017B 2.88
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.97
VAXART, INC (VXRT) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
Trillium Therapeutics (TRIL) Canada $0.011B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.009B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.009B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.007B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.006B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Can-Fite Biopharma (CANF) Israel $0.005B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00